ID

18327

Description

Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00075270

Link

https://clinicaltrials.gov/show/NCT00075270

Keywords

Versions (2)
  1. 10/31/16 10/31/16 -
  2. 10/31/16 10/31/16 -
Uploaded on

October 31, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Neoplasms, Breast NCT00075270

English

Eligibility Neoplasms, Breast NCT00075270

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
able to swallow an oral medication
Description

Able to swallow oral medication

Data type

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
cardiac ejection fraction within the institutional range of normal as measured by echocardiogram
Description

Cardiac ejection fraction | Echocardiography

Data type

boolean

Alias
UMLS CUI [1]
C0232174
UMLS CUI [2]
C0013516
adequate kidney and liver function
Description

Renal function | Liver function

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
adequate bone marrow function
Description

Bone Marrow function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
tumor tissue available for testing
Description

Tumor tissue Available Testing

Data type

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C0039593
prior adjuvant or neoadjuvant therapy is permitted with an anthracycline or anthracenedione-containing regimen however, subjects must have had cumulative doses of less than 360 mg/m2 of doxorubicin, 720 mg/m2 of epirubicin, or 72 mg/m2 of mitoxantrone
Description

Adjuvant therapy | Neoadjuvant Therapy | Anthracycline Antibiotics | Anthraquinones | Doxorubicin Cumulative Dose | Epirubicin Cumulative Dose | Mitoxantrone Cumulative Dose

Data type

boolean

Alias
UMLS CUI [1]
C0677850
UMLS CUI [2]
C0600558
UMLS CUI [3]
C0003234
UMLS CUI [4]
C0003174
UMLS CUI [5,1]
C0013089
UMLS CUI [5,2]
C2986497
UMLS CUI [6,1]
C0014582
UMLS CUI [6,2]
C2986497
UMLS CUI [7,1]
C0026259
UMLS CUI [7,2]
C2986497
no her2/neu overexpression in tumor tissue tested or status unknown if tissue has never been tested
Description

HER2/NEU Overexpression Tumor tissue | HER2/Neu Status Unknown

Data type

boolean

Alias
UMLS CUI [1,1]
C3810543
UMLS CUI [1,2]
C1514559
UMLS CUI [1,3]
C0475358
UMLS CUI [2]
C2348910
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment regimens for advanced or metastatic breast cancer.
Description

Prior Therapy Advanced breast cancer | Prior Therapy Breast Carcinoma Metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C3495917
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0678222
UMLS CUI [2,3]
C0036525
pregnant or lactating
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
conditions that would effect the absorption of an oral drug
Description

Condition Affecting drug absorption

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0678745
active infection
Description

Communicable Disease

Data type

boolean

Alias
UMLS CUI [1]
C0009450
brain metastases
Description

Metastatic malignant neoplasm to brain

Data type

boolean

Alias
UMLS CUI [1]
C0220650
treatment with egfr (endothelial growth factor receptor) inhibitor.
Description

Endothelial Growth Factor Receptor Inhibitors

Data type

boolean

Alias
UMLS CUI [1]
C2267120
known hypersensitivity to taxol or excipients of taxol
Description

HypersensitivityTaxol | Hypersensitivity Taxol Excipient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0678133
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0678133
UMLS CUI [2,3]
C0015237
peripheral neuropathy of grade 2 or greater is not permitted
Description

Peripheral Neuropathy | CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
severe cardiovascular disease or cardiac disease requiring a device.
Description

Cardiovascular Disease Severe | Cardiovascular Disease Requirement Medical Device

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0025080
serious medical or psychiatric disorder that would interfere with the patient's safety or informed consent.
Description

Disease Serious Interferes with patient safety | Disease Serious Interferes with Informed Consent | Mental disorder Interferes with patient safety | Mental disorder Interferes with Informed Consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C1113679
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C0021430
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C1113679
UMLS CUI [4,1]
C0004936
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0021430
Back to the top of the page

Similar models

Eligibility Neoplasms, Breast NCT00075270

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Able to swallow oral medication
Item
able to swallow an oral medication
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Cardiac ejection fraction | Echocardiography
Item
cardiac ejection fraction within the institutional range of normal as measured by echocardiogram
boolean
C0232174 (UMLS CUI [1])
C0013516 (UMLS CUI [2])
Renal function | Liver function
Item
adequate kidney and liver function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
Bone Marrow function
Item
adequate bone marrow function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
Tumor tissue Available Testing
Item
tumor tissue available for testing
boolean
C0475358 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0039593 (UMLS CUI [1,3])
Adjuvant therapy | Neoadjuvant Therapy | Anthracycline Antibiotics | Anthraquinones | Doxorubicin Cumulative Dose | Epirubicin Cumulative Dose | Mitoxantrone Cumulative Dose
Item
prior adjuvant or neoadjuvant therapy is permitted with an anthracycline or anthracenedione-containing regimen however, subjects must have had cumulative doses of less than 360 mg/m2 of doxorubicin, 720 mg/m2 of epirubicin, or 72 mg/m2 of mitoxantrone
boolean
C0677850 (UMLS CUI [1])
C0600558 (UMLS CUI [2])
C0003234 (UMLS CUI [3])
C0003174 (UMLS CUI [4])
C0013089 (UMLS CUI [5,1])
C2986497 (UMLS CUI [5,2])
C0014582 (UMLS CUI [6,1])
C2986497 (UMLS CUI [6,2])
C0026259 (UMLS CUI [7,1])
C2986497 (UMLS CUI [7,2])
HER2/NEU Overexpression Tumor tissue | HER2/Neu Status Unknown
Item
no her2/neu overexpression in tumor tissue tested or status unknown if tissue has never been tested
boolean
C3810543 (UMLS CUI [1,1])
C1514559 (UMLS CUI [1,2])
C0475358 (UMLS CUI [1,3])
C2348910 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Prior Therapy Advanced breast cancer | Prior Therapy Breast Carcinoma Metastatic
Item
prior treatment regimens for advanced or metastatic breast cancer.
boolean
C1514463 (UMLS CUI [1,1])
C3495917 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0036525 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Condition Affecting drug absorption
Item
conditions that would effect the absorption of an oral drug
boolean
C0348080 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])
Endothelial Growth Factor Receptor Inhibitors
Item
treatment with egfr (endothelial growth factor receptor) inhibitor.
boolean
C2267120 (UMLS CUI [1])
HypersensitivityTaxol | Hypersensitivity Taxol Excipient
Item
known hypersensitivity to taxol or excipients of taxol
boolean
C0020517 (UMLS CUI [1,1])
C0678133 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0678133 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy of grade 2 or greater is not permitted
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Cardiovascular Disease Severe | Cardiovascular Disease Requirement Medical Device
Item
severe cardiovascular disease or cardiac disease requiring a device.
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0025080 (UMLS CUI [2,3])
Disease Serious Interferes with patient safety | Disease Serious Interferes with Informed Consent | Mental disorder Interferes with patient safety | Mental disorder Interferes with Informed Consent
Item
serious medical or psychiatric disorder that would interfere with the patient's safety or informed consent.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C1113679 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0021430 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1113679 (UMLS CUI [3,3])
C0004936 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial